Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations

Immunizing pregnant women is a promising strategy to reduce infectious disease-related morbidity and mortality in pregnant women and their infants. Important pre-requisites for the successful introduction of new vaccines for immunization in pregnancy include political commitment and adequate financial resources: trained, committed and sufficient numbers of healthcare workers to deliver the vaccines; close integration of immunization programs with antenatal care and Maternal and Child Health services; adequate access to antenatal care by pregnant women in the country (especially in low and middle-income countries (LMIC)); and a high proportion of births occurring in health facilities (to ensure maternal and neonatal follow-up can be done). The framework needed to advance a vaccine program from product licensure to successful country-level implementation includes establishing and organizing evidence for anticipated vaccine program impact, developing supportive policies, and translating policies into local action. International and national coordination efforts, proactive planning from conception to implementation of the programs (including country-level policy making, planning, and implementation, regulatory guidance, pharmacovigilance) and country-specific and cultural factors must be taken into account during the vaccines introduction

Risk factors for canine echinococcosis in an endemic area of Peru

This study was funded by Consejo Nacional de Ciencia y Tecnologia (CONCYTEC), Lima, Peru. We thank Dr. Peter Schantz for constructive comments and review of the manuscript.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concyte

Screening for cystic echinococcosis in an endemic region of Peru using portable ultrasonography and the enzyme-linked immunoelectrotransfer blot (EITB) assay

Financial support for this study was received from Consejo Nacional de Ciencia y Tecnología (CONCYTEC), Lima, Peru. The methods used in the present study comply with current Peruvian law governing the participation of human subjects in biomedical research.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concyte

Field evaluation of a coproantigen enzyme-linked immunosorbent assay for diagnosis of canine echinococcosis in a rural Andean village in Peru

This study was funded by Consejo Nacional de Ciencia y Tecnolog ́ıa (CONCYTEC).We wish to thank Dr. Peter Schantz for manuscript review and the people and authoritiesof the farming cooperative of Tupac Amaru in Junin, Peru.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concyte

Intestinal parasites of the grey fox (Pseudalopex culpaeus) in the central Peruvian Andes

This study was funded in part by NIH grant no.U01A135894-01 and funds by CONCYTEC, Lima, Peru.The authors thank J.D. Moro, N. Perez-Palma, J.B. Phu, D.Sara, Amanda Chavez and Eva Casas for editorial help.We also thank Armando Gonzales, Cesar Gavidia, NestorFalcon for helpful comments and M. Gamarra and R.Zarate from Tupac Amaru for their cooperation.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concyte

Human hydatidosis in the central Andes of Peru: Evolution of the disease over 3 years

This study was funded in part by the National Institutes of Health (grant no. U01-A135894, awarded to The Johns Hopkins University), the RG-ER Fund, and Consejo Nacional de Ciencia y Tecnologı´a (CONCYTEC; Lima, Peru).Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concyte